Recent Advances on the Biology, Prognosis and Treatment of Rhabdomyosarcoma
which, in turn, represent 7% of all pediatric malignancies 1 .In one of the most recent epidemiological studies published in the USA, covering the period from 2003 to 2017, the age-adjusted RMS incidence rate was 4.58 cases per million children, with an average annual percent change of 0.3%.The five-year relative survival rate was 68% 2 .
Authors
- George Ι. Lambrou (ORCID: https://orcid.org/0000-0001-8389-1360)
- Konstantinos Pantelakis
Publication Details
- Journal
- Journal of Research and Practice on the Musculoskeletal System
- Published
- 2025-05-30
- DOI
- https://doi.org/10.22540/jrpms-09-046
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00